Why did EMS workers neglect Tyre Nichols?; Eisai reports first U.S. sales of new Alzheimer’s drug

For 19 minutes, EMS workers took no action to help Tyre Nichols. His death points to longstanding issues of bias in emergency medicine.

February 6, 2023 Check out STAT+

Sponsored By

Christine Kao/STAT 'They were his best shot. And they failed to help': Why did EMS workers neglect Tyre Nichols? For 19 minutes, EMS workers took no action to help Tyre Nichols. His death points to longstanding issues of bias in emergency medicine. By Marion Renault STAT+ | Eisai reports first U.S. sales of newly approved treatment for Alzheimer's disease The first U.S. sales of Leqembi were recorded on Jan. 18, Eisai said during its presentation of financial results. By Adam Feuerstein STAT+ | FDA grants priority review for Sage's rapid-acting treatment for depression The agency has not indicated yet whether it will convene an advisory panel of outside experts to review the zuranolone clinical data. By Adam Feuerstein Photo illustration: Casey Shenery for STAT After 'losing my life' caring for a sick partner, a professor examines the U.S. caregiver crisis For Laura Mauldin, the trauma of caring for her partner for years brought into sharp focus the ways in which caregivers are hung out to dry.  By Isabella Cueto Opinion: Mindstrong's demise and the future of mental health care Mindstrong discovered a fundamental truth: Americans value mental health extremely highly — until they have to pay for it. By Roy Perlis Patient's race and method of dialysis are linked to higher risk of blood infection Hispanic, Latino and non-Hispanic Black Americans had more infections, particularly if receiving dialysis through a central venous catheter. By Isabella Cueto ALEX EDELMAN/AFP via Getty Images Opinion: Covid convalescent plasma: the 'little engine that could' The withdrawal of monoclonal antibody therapy leaves Covid convalescent plasma as a key option for immunocompromised people and others. By Michael J. Joyner and Nigel Paneth and Arturo Casadevall

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Daily Recap? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

REPORTS NEWSLETTERS EVENTS STAT+

STAT, 1 Exchange Place, Boston, MA ©2023, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser